NCT06139016View on ClinicalTrials.gov

Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment

NAEnrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions

Depression

Interventions

DEVICE

Virtual reality

Virtual reality gear and content will be used to affect and control the audiovisual perception of patients during a single treatment with ketamine/esketamine

Trial Locations (1)

06520

Yale Psychiatry Hospital Interventional Psychiatry Services (IPS) unit, New Haven

All Listed Sponsors

lead

Yale University

OTHER